Table 3.

SVR12 Rates for Key Patient Subgroups

Patient Subgroup	n/N	SVR12 (95% CI)
Treatment duration
12 weeks	59/62	95% (87‐98)
16 weeks	66/69	96% (88‐99)
Prior HCV treatment
Naive	39/40	98% (87‐99)
Any experience	86/91	95% (88‐98)
SOF‐based	41/42	98% (88‐99)
Compensated cirrhosis
With	84/87	97% (90‐99)
Without	41/44	93% (82‐98)